. . . . "Lapatinib: a review of its use in the treatment of HER2-overexpressing, trastuzumab-refractory, advanced or metastatic breast cancer"@ast . . "\u0645\u0642\u0627\u0644\u0629 \u0639\u0644\u0645\u064A\u0629 \u0646\u0634\u0631\u062A \u0641\u064A \u0623\u0643\u062A\u0648\u0628\u0631 2009"@ar . . . . . . . . . . . . . . . "2125-2148" . . . . . . . "10.2165/11203240-000000000-00000" . . . . . . . . . "2009-10-01T00:00:00Z"^^ . "Lapatinib: a review of its use in the treatment of HER2-overexpressing, trastuzumab-refractory, advanced or metastatic breast cancer"@nl . . . . . . "69" . . . "Lapatinib: a review of its use in the treatment of HER2-overexpressing, trastuzumab-refractory, advanced or metastatic breast cancer"@en . . . . . . . . . . . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en 2009"@ast . "Lapatinib: a review of its use in the treatment of HER2-overexpressing, trastuzumab-refractory, advanced or metastatic breast cancer"@en . . . . . . . . . . . . . . . . . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0436\u043E\u0432\u0442\u043D\u0456 2009"@uk . . "wetenschappelijk artikel"@nl . . . "Lapatinib: a review of its use in the treatment of HER2-overexpressing, trastuzumab-refractory, advanced or metastatic breast cancer"@en . . . . . . "vedeck\u00FD \u010Dl\u00E1nok"@sk . "article cient\u00EDfic"@ca . "Lapatinib: a review of its use in the treatment of HER2-overexpressing, trastuzumab-refractory, advanced or metastatic breast cancer"@ast . . . . . "bilimsel makale"@tr . . . . . . . . . . . "1029867297" . . "Lapatinib: a review of its use in the treatment of HER2-overexpressing, trastuzumab-refractory, advanced or metastatic breast cancer"@ast . . . . "vetenskaplig artikel"@sv . . . . . . "article scientifique"@fr . "videnskabelig artikel"@da . . "articolo scientifico"@it . . . . . . . . "19791830" . . . . . . "Lapatinib: a review of its use in the treatment of HER2-overexpressing, trastuzumab-refractory, advanced or metastatic breast cancer"@nl . . . . . . . . . . . . . . . "artigo cient\u00EDfico"@pt . . . . . . . . "James E Frampton" . . . . "15" . . . . . . . . . "wissenschaftlicher Artikel"@de . . . "scientific article published on October 2009"@en . "v\u011Bdeck\u00FD \u010Dl\u00E1nek"@cs . . . "Lapatinib: a review of its use in the treatment of HER2-overexpressing, trastuzumab-refractory, advanced or metastatic breast cancer"@en . . "Lapatinib: a review of its use in the treatment of HER2-overexpressing, trastuzumab-refractory, advanced or metastatic breast cancer"@nl . . . . . "\u043D\u0430\u0443\u0447\u043D\u0438 \u0447\u043B\u0430\u043D\u0430\u043A"@sr . . . . . . . . . . . . . . . . . . . . . . . . . . .